SILVERARC CAPITAL MANAGEMENT, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001816307

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q3 2026 · 64 positions · Total reported value $784.53M · Top-10 concentration 54.6% · Updated 2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

Turnover: 64.6% · 15 new · 20 cut · 18 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -8.8% · vs SPY -10.9% · Prev Value $855.33M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -4.7% · vs SPY -6.9% · Latest Value $784.53M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, SILVERARC CAPITAL MANAGEMENT, LLC disclosed 64 equity positions with a combined reported value of $784.53M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 54.6% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were KOD ($71.12M), CELC ($63.87M), COGT ($50.42M). By sector, the heaviest allocations are Health Care 95.8%, Financials 3.3%. Versus the prior quarter, allocation shifted toward Financials (+1.4pp), Other (+0.9pp) and away from Health Care (-2.3pp).

Versus the prior quarter, SILVERARC CAPITAL MANAGEMENT, LLC opened 15 new positions, trimmed 20 and fully exited 18, a turnover rate of 64.6% of positions. The portfolio's overlap with the prior quarter was 60% of names.

The largest new positions opened in Q3 2026 were CLDX ($12.01M), KRSP ($8.71M), DARE ($6.80M).

Of the 18 positions fully exited versus the prior quarter, the largest were VCYT ($18.68M), GH ($14.98M), TRVI ($12.65M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • CLDX CELLDEX THERAPEUTICS INC NEW · $12.01M
  • KRSP RICE ACQUISITION CORP 3 · $8.71M
  • DARE YARROW BIOSCIENCE INC · $6.80M
  • ARCT ARCTURUS THERAPEUTICS HLDGS · $6.30M
  • KNSA KINIKSA PHARMACEUTICALS INTL · $5.65M
  • EVMN EVOMMUNE INC · $4.91M
  • FTH FAETH THERAPEUTICS INC · $3.69M
  • RACD RESEARCH ALLIANCE CORP IV · $3.50M

Fully Exited (vs previous quarter)

  • VCYT VERACYTE INC · prev qtr: $18.68M
  • GH GUARDANT HEALTH INC · prev qtr: $14.98M
  • TRVI TREVI THERAPEUTICS INC · prev qtr: $12.65M
  • MANE VERADERMICS INC · prev qtr: $11.68M
  • XENE XENON PHARMACEUTICALS INC · prev qtr: $11.28M
  • AVTX AVALO THERAPEUTICS INC · prev qtr: $9.25M
  • WGS GENEDX HOLDINGS CORP · prev qtr: $8.39M
  • ARTV ARTIVA BIOTHERAPEUTICS INC · prev qtr: $5.09M

Insider Transactions (Form 4)

Latest SILVERARC CAPITAL MANAGEMENT, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Silverarc Capital Management is an SEC-registered 13F filer based in Boston, MA, United States. As of Q2 2026 it reported 67 US equity positions with a combined value of $855.33M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: BOSTON, MA, United States
  • SEC registration: 801-116845 (status: Approved), registered 2019-06-21
  • Regulatory AUM (Form ADV): $1.61B as of 2026-03-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 2 hedge funds
  • Website: silverarccapital.com

Portfolio Structure

  • 67 positions · $855.33M reported value (Q2 2026)
  • Top 10 holdings = 47.1% of reported value
  • Largest position: ASND (ASCENDIS PHARMA A/S) at 6.4%
  • Average position size: $12.77M

Sector Tilt

  • Health Care 98.1%
  • Financials 1.9%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 19 new, 16 added, 28 reduced, 20 exited
  • 4 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: Aggressive growth tilt in Health Care, with significant new positions and share increases, suggesting bullish sentiment on biotech/therapeutics. 2. Key moves: - Added: KOD (+6.57 wt%), CELC (+2.01 wt%), SGMT (+2.07 wt%), BIIB (+2.03 wt%) (largest absolute increases). - Reduced: ASND (-2.01 wt%), URGN (-0.65 wt%) (largest absolute decreases). 3. Portfolio structure: Highly active, concentrated (64 positions), Health Care-dominated (100% of top 10), high-risk (small/mid-cap biotech focus). 4. Per-holding one-liner: - KOD: Unverified (biotech/ophthalmology). - CELC: Unverified (cancer therapeutics). - COGT: Unverified (immune disorders). - URGN: Unverified (urology treatments). - IMNM: Unverified (cancer diagnostics). - SGMT: Unverified (metabolic disorders). - ASND: Unverified (growth disorders). - RYTM: Unverified (obesity treatments). - BIIB: Unverified (neurology/MS). - IMVT: Unverified (autoimmune therapies). 5. Style summary: Concentrated, high-conviction Health Care fund aggressively adding biotech names while trimming select positions.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-14 20:37

Sector Allocation

Health Care 95.8%
Financials 3.3%
Other 0.9%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 750.17K $71.12M 9.06%
9.06%
Add
2 803.19K $63.87M 8.14%
8.14%
Add
3 1.57M $50.42M 6.43%
6.43%
Add
4 1.15M $46.67M 5.95%
5.95%
Reduce
5 2.09M $45.01M 5.74%
5.74%
Add
6 3.75M $37.01M 4.72%
4.72%
Add
7 152.18K $34.67M 4.42%
4.42%
Reduce
8 348.32K $33.17M 4.23%
4.23%
Add
9 112.79K $25.48M 3.25%
3.25%
Add
10 624.05K $21.08M 2.69%
2.69%
Add
11 236.58K $20.83M 2.65%
2.65%
Reduce
12 247.92K $20.65M 2.63%
2.63%
Reduce
13 1.33M $19.50M 2.49%
2.49%
Add
14 175.70K $17.40M 2.22%
2.22%
Add
15 5.95M $14.82M 1.89%
1.89%
Add
16 151.15K $13.46M 1.72%
1.72%
Add
17 345.95K $13.17M 1.68%
1.68%
Reduce
18 1.21M $12.83M 1.64%
1.64%
Add
19 300.43K $12.17M 1.55%
1.55%
Add
20 370.70K $12.01M 1.53%
1.53%
New
21 3.45M $11.50M 1.47%
1.47%
Add
22 378.35K $10.78M 1.37%
1.37%
Add
23 3.95M $9.40M 1.20%
1.20%
Add
24 6.57M $9.13M 1.16%
1.16%
Add
25 334.06K $9.01M 1.15%
1.15%
Reduce
26 717.36K $8.92M 1.14%
1.14%
Add
27 853.88K $8.71M 1.11%
1.11%
New
28 3.59M $8.54M 1.09%
1.09%
Add
29 1.52M $7.84M 1.00%
1.00%
Add
30 125.08K $7.12M 0.91%
0.91%
Reduce
31 301.92K $6.80M 0.87%
0.87%
New
32 5.36M $6.32M 0.81%
0.81%
Add
33 459.90K $6.30M 0.80%
0.80%
New
34 525.00K $6.26M 0.80%
0.80%
Add
35 19.75K $5.75M 0.73%
0.73%
Reduce
36 75.70K $5.65M 0.72%
0.72%
New
37 121.45K $5.57M 0.71%
0.71%
Reduce
38 760.34K $5.50M 0.70%
0.70%
Add
39 594.03K $4.91M 0.62%
0.62%
New
40 247.42K $4.65M 0.59%
0.59%
Reduce
41 443.11K $4.43M 0.56%
0.56%
Reduce
42 404.73K $4.38M 0.56%
0.56%
Add
43 124.10K $3.69M 0.47%
0.47%
New
44 693.44K $3.64M 0.46%
0.46%
Add
45 301.96K $3.50M 0.45%
0.45%
New
46 216.62K $3.47M 0.44%
0.44%
New
47 2.34M $3.15M 0.40%
0.40%
New
48 47.31K $3.10M 0.40%
0.40%
Reduce
49 2.14M $2.46M 0.31%
0.31%
Hold
50 200.26K $2.20M 0.28%
0.28%
New

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 70% R 70% F1 70% (modelled on 2026-Q2; 7/10 hit)

Low-confidence forecast This fund replaces about 43% of its Top-10 each quarter and backtests at F1 60% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (11 quarters)

Avg precision 60% · recall 60% · F1 60% · avg rank error 3.4 · Top-10 turnover 43%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 60% 60% 60% MRUS · NUVL · MORF · PSTX · MGNX · RCKT · MDT · SNY · ORIC · CLDX MRUS · SLDB · MORF · ORIC · MRSN · CLDX · RNAM · NUVL · PRAX · PSTX
2024-Q2 70% 70% 70% MRUS · SLDB · MORF · ORIC · MRSN · CLDX · RNAM · PSTX · AKRO · NUVL MRUS · NUVL · RNAM · URGN · ERAS · MORF · AKRO · CLDX · ITCI · PSTX
2024-Q3 60% 60% 60% NUVL · MRUS · RNAM · ERAS · URGN · AKRO · MORF · ITCI · CLDX · PSTX NUVL · MRUS · INSM · RNAM · ERAS · AKRO · VCYT · RYTM · COGT · ITCI
2024-Q4 80% 80% 80% NUVL · MRUS · INSM · RNAM · ERAS · AKRO · VCYT · RYTM · ITCI · COGT NUVL · MRUS · INSM · VRNA · AKRO · VCYT · ERAS · PLRX · RNAM · RYTM
2025-Q1 70% 70% 70% NUVL · INSM · MRUS · VRNA · VCYT · AKRO · PLRX · ERAS · RYTM · RNAM VRNA · MRUS · NUVL · AKRO · INSM · KALV · VCYT · RYTM · SNDX · URGN
2025-Q2 70% 70% 70% VRNA · MRUS · NUVL · AKRO · INSM · KALV · VCYT · RYTM · SNDX · URGN MRUS · AKRO · VRNA · URGN · RYTM · INSM · KALV · NBIX · ETNB · ORIC
2025-Q3 40% 40% 40% MRUS · AKRO · VRNA · URGN · RYTM · INSM · KALV · NBIX · ETNB · ORIC ABVX · RYTM · RNAM · NUVL · URGN · AKRO · INSM · DNTH · QURE · CGON
2025-Q4 40% 40% 40% ABVX · RNAM · RYTM · NUVL · URGN · AKRO · QURE · DNTH · INSM · UTHR ABVX · COGT · URGN · CELC · NUVL · DNTH · KOD · PRAX · IMNM · GUTS
2026-Q1 60% 60% 60% ABVX · COGT · CELC · URGN · NUVL · DNTH · KOD · PRAX · IMNM · GUTS KALV · DNTH · COGT · IMNM · KOD · NUVL · ABVX · GLUE · ERAS · ASND
2026-Q2 40% 40% 40% KALV · COGT · DNTH · IMNM · KOD · GLUE · NUVL · ASND · ABVX · ERAS ASND · CELC · COGT · URGN · IMNM · DNTH · RYTM · ORKA · ELVN · IMVT
2026-Q3 ★ 70% 70% 70% ASND · CELC · COGT · URGN · IMNM · RYTM · ORKA · DNTH · ELVN · IMVT KOD · CELC · COGT · URGN · IMNM · SGMT · ASND · RYTM · BIIB · IMVT

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-12. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-12 Trading days31 Holdings3 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-12, and will update as prices arrive.

Portfolio return+14.94%Buy & hold
QQQ synthetic benchmark-11.15%Liquidity weighted
Excess return+26.09%vs benchmark
Barra annualised vol92.6%Model estimate
Realised vol80.0%Annualised in window
Weighted beta1.78Raw exposure
Factor / specific risk30% / 70%Share of variance
Top-10 concentration100.0%Of reported value
Portfolio value (start = 100)77.487.597.6107.6117.710-0110-2211-12SILVERARC CAPITAL MANAGEMENT, LLCQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)+14.94%Disclosed long book
QQQ synthetic benchmark-11.15%Liquidity-weighted constituents
Model universe, equal weight+2.04%Opportunity-cost reference
Excess return+26.09%Portfolio − benchmark
Arithmetic return sum+17.74%Difference vs compounded is the cross term
Weighted raw beta1.78Weighted holding betas
Realised volatility (annualised)79.97%Daily returns in window
Barra model volatility (annualised)92.62%Factor + specific
Factor share of variance30.2%Barra factors
Specific share of variance69.8%Stock residuals
Reported value$41.1M13F long US equity

2. Return attribution

The +17.74% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 -3.16% -17.8%
Momentum & Growth 3 +0.76% 4.3%
Volatility & Tail Risk 7 -9.24% -52.1%
Industry 12 +9.47% 53.4%
Specific 1 +19.91% 112.2%
Return attribution (style + industry, %)-17.9-8.9+0.0+8.9+17.9Kurtosis-0.82Amihud Illiquidity+0.82Max Drawdown+0.91Leverage (Downside Vol)-1.29Skewness-1.46Turnover-1.94Momentum-2.34Growth+2.57Size+3.02Beta+4.65Mid Cap-4.87Residual Volatility+5.32Health Care+9.47Historical Volatility-16.54
Factor Type Exposure Factor return Contribution Share of |return|
Specific Specific — — +19.91% 112.2%
Health Care Industry +1.00 +9.47% +9.47% 53.4%
Residual Volatility Style +2.48 +2.15% +5.32% 30.0%
Beta Style +0.95 +4.92% +4.65% 26.2%
Size Style -1.56 -1.93% +3.02% 17.0%
Growth Style +1.71 +1.50% +2.57% 14.5%
Max Drawdown Style -0.90 -1.01% +0.91% 5.1%
Amihud Illiquidity Style +2.74 +0.30% +0.82% 4.6%
Short-term Reversal Style +0.49 +1.12% +0.54% 3.1%
Non-linear Size Style +2.89 +0.07% +0.20% 1.1%
Liquidity Style +1.91 -0.20% -0.39% -2.2%
Kurtosis Style -0.13 +6.17% -0.82% -4.6%
Leverage (Downside Vol) Style +0.42 -3.05% -1.29% -7.3%
Skewness Style +0.31 -4.77% -1.46% -8.2%
Turnover Style +0.45 -4.35% -1.94% -10.9%
Momentum Style +0.71 -3.32% -2.34% -13.2%
Mid Cap Style +2.54 -1.92% -4.87% -27.4%
Historical Volatility Style +1.68 -9.82% -16.54% -93.2%

3. Risk attribution

Annualised volatility is 92.62%; factor risk explains 30.2% of variance and specific risk 69.8%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-75.4-37.7+0.0+37.7+75.4Max Drawdown-1.06Momentum+0.40Size+0.50Leverage (Downside Vol)+0.57Short-term Reversal+0.95Non-linear Size+0.98Liquidity+2.60Mid Cap+3.05Health Care+3.08Beta+3.51Historical Volatility+4.61Residual Volatility+5.11Growth+5.53Specific+69.81
Factor Type Exposure Share of variance Vol contribution Share of vol
Specific Specific — 69.8% +64.66% 64.7%
Growth Style +1.71 5.5% +5.12% 5.1%
Residual Volatility Style +2.48 5.1% +4.73% 4.7%
Historical Volatility Style +1.68 4.6% +4.27% 4.3%
Beta Style +0.95 3.5% +3.25% 3.2%
Health Care Industry +1.00 3.1% +2.85% 2.9%
Mid Cap Style +2.54 3.0% +2.82% 2.8%
Liquidity Style +1.91 2.6% +2.40% 2.4%
Non-linear Size Style +2.89 1.0% +0.91% 0.9%
Short-term Reversal Style +0.49 0.9% +0.88% 0.9%
Leverage (Downside Vol) Style +0.42 0.6% +0.53% 0.5%
Size Style -1.56 0.5% +0.46% 0.5%
Momentum Style +0.71 0.4% +0.37% 0.4%
Max Drawdown Style -0.90 -1.1% -0.98% -1.0%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-2.0-0.70.72.03.3Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -1.56 +2.10 -3.66
Non-linear Size +2.89 +1.68 +1.21
Mid Cap +2.54 +0.13 +2.41
Beta +0.95 +1.29 -0.35
Momentum +0.71 +0.72 -0.01
Short-term Reversal +0.49 -0.64 +1.13
Residual Volatility +2.48 -0.40 +2.88
Historical Volatility +1.69 +0.86 +0.83
Liquidity +1.91 +0.11 +1.80
Amihud Illiquidity +2.74 +1.16 +1.58
Turnover +0.45 +0.21 +0.24
Growth +1.71 +0.58 +1.12
Leverage (Downside Vol) +0.42 +0.14 +0.28
Skewness +0.31 +0.24 +0.07
Kurtosis -0.13 +0.21 -0.35
Max Drawdown -0.90 -0.08 -0.81

5. Industry allocation & Brinson

Industry allocation (weight, %)-10.020.050.080.0110.0Information TechnologyCommunication ServicesUtilitiesConsumer StaplesConsumer DiscretionaryIndustrialsHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Health Care 100.0% 1.7% +14.30% +9.50% +19.56% +0.08% +4.71% +14.13%
Information Technology 0.0% 73.6% +0.00% -16.67% +4.61% +12.27% -12.27% +12.27%
Communication Services 0.0% 2.6% +0.00% -12.15% +0.05% +0.32% -0.32% +0.32%
Utilities 0.0% 0.8% +0.00% +10.14% -0.16% -0.08% +0.08% -0.08%
Consumer Staples 0.0% 0.8% +0.00% +15.33% -0.22% -0.13% +0.13% -0.13%
Consumer Discretionary 0.0% 8.8% +0.00% +5.93% -1.44% -0.52% +0.52% -0.52%
Industrials 0.0% 11.1% +0.00% +7.87% -2.03% -0.87% +0.87% -0.87%
Total +20.28% +11.03% -6.23% +25.08%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
SGMT SAGIMET BIOSCIENCES INC Health Care 90.12% +15.49% +13.96% Add
CTNM CONTINEUM THERAPEUTICS INC Health Care 5.19% -19.75% -1.03% Reduce
MRNA MODERNA INC Health Care 4.69% +29.14% +1.37% New
Contribution rank Symbol Sector Weight Return Contribution
1 SGMT Health Care 90.12% +15.49% +13.96%
2 MRNA Health Care 4.69% +29.14% +1.37%
3 CTNM Health Care 5.19% -19.75% -1.03%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-12 (31 trading days), the reported portfolio returned +14.94%, versus -11.15% for the QQQ synthetic benchmark — an excess of +26.09%.
  2. Return attribution: the largest positive style/industry contributions came from Health Care +9.47%, Residual Volatility +5.32%, Beta +4.65%; the largest drags came from Historical Volatility -16.54%, Mid Cap -4.87%, Momentum -2.34%. Specific (stock-level) return contributed +19.91%.
  3. Risk attribution: Barra model volatility is 92.62% annualised; factor risk explains 30% of variance and specific risk 70%. The largest factor risk sources are Growth 5.5%, Residual Volatility 5.1%, Historical Volatility 4.6%.
  4. Style tilt: size -1.56, momentum +0.71, volatility +1.69, liquidity +1.91; the weighted raw beta is 1.78. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+98.3 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +20.28%, selection +11.03% and interaction -6.23%.
  6. Concentration: the top-10 positions are 100.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did SILVERARC CAPITAL MANAGEMENT, LLC buy in 2026-Q3?

In its 2026-Q3 13F filing, SILVERARC CAPITAL MANAGEMENT, LLC reported 64 equity positions worth $784.53M in aggregate; its largest disclosed positions were KOD ($71.12M), CELC ($63.87M), COGT ($50.42M).

How large is SILVERARC CAPITAL MANAGEMENT, LLC's portfolio?

SILVERARC CAPITAL MANAGEMENT, LLC reported $784.53M of long equity holdings across 64 positions as of 2026-Q3. Top-10 holdings account for 54.6% of reported value.

What is SILVERARC CAPITAL MANAGEMENT, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/silverarc-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →